Showing results (1-10 of 269) with videos related to
Sort By:
Pageof 27
Expert Review of Anticancer Therapy|November 10, 2009
Lapatinib plus letrozole for postmenopausal patients with advanced HER2(+)/HR(+) breast cancerValentina GuarneriThe Oncologist|October 2, 2004
Safety of intravenous and oral bisphosphonates and compliance with dosing regimensPierFranco Conte, Valentina GuarneriClinical Breast Cancer|May 22, 2012
The next generation of biologic agents: therapeutic role in relation to existing therapies in metastatic breast cancerPierFranco Conte, Valentina GuarneriThe Oncologist|July 18, 2009
Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapyValentina Guarneri, PierFranco ConteEuropean Journal of Nuclear Medicine and Molecular Imaging|April 27, 2004
The curability of breast cancer and the treatment of advanced diseaseValentina Guarneri, Pier Franco ConteCurrent Opinion in Oncology|September 8, 2023
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeuticsOttavia Amato, Valentina Guarneri, Fabio GirardiClinical Breast Cancer|February 14, 2008
Evolving nonendocrine therapeutic options for metastatic breast cancer: how adjuvant chemotherapy influences treatmentPierfranco Conte, Valentina Guarneri, Carmelo BengalaCell Stress|September 20, 2019
Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progressionAntonio Sica, Valentina Guarneri, Alessandra GennariJournal of the National Cancer Institute. Monographs|November 2, 2011
Biomarkers predicting clinical benefit: fact or fiction?Valentina Guarneri, Elena Barbieri, Pierfranco ConteCurrent Opinion in Oncology|October 17, 2018
Escalation and de-escalation in HER2 positive early breast cancerMaria Vittoria Dieci, Grazia Vernaci, Valentina GuarneriPageof 27